{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:16:30Z","timestamp":1789830990446,"version":"4.0.1"},"reference-count":45,"publisher":"Society of Nuclear Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.2967\/jnumed.122.263864","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T20:30:16Z","timestamp":1651177816000},"page":"1949-1955","source":"Crossref","is-referenced-by-count":11,"title":["Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET"],"prefix":"10.2967","volume":"63","author":[{"given":"Allen F.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade P.","family":"Winton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenelle","family":"Stauff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna","family":"Arteaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Niedbala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.H.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Viglianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"2025012107400784000_63.12.1949.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(70)80116-7"},{"key":"2025012107400784000_63.12.1949.2","first-page":"1038","article-title":"A new and superior adrenal scanning agent, NP-59","volume":"16","author":"Sarkar","year":"1975","journal-title":"J Nucl Med."},{"key":"2025012107400784000_63.12.1949.3","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.287"},{"key":"2025012107400784000_63.12.1949.4","doi-asserted-by":"crossref","first-page":"317934","DOI":"10.1155\/2013\/317934","article-title":"NP-59 SPECT\/CT imaging in stage 1 hypertensive and atypical primary aldosteronism: a 5-year retrospective analysis of clinicolaboratory and imaging features","volume":"2013","author":"Chen","year":"2013","journal-title":"ScientificWorldJournal."},{"key":"2025012107400784000_63.12.1949.5","first-page":"209787","article-title":"Diagnostic value of I-131 NP-59 SPECT\/CT scintigraphy in patients with subclinical or atypical features of primary aldosteronism","volume":"2011","author":"Chen","year":"2011","journal-title":"J Biomed Biotechnol."},{"key":"2025012107400784000_63.12.1949.6","first-page":"526","article-title":"Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging","volume":"31","author":"Kazerooni","year":"1990","journal-title":"J Nucl Med."},{"key":"2025012107400784000_63.12.1949.7","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s00261-015-0452-6","article-title":"Adrenal 131I-6\u03b2-iodomethylnorcholesterol scintigraphy in choosing the side for adrenalectomy in bilateral adrenal tumors with subclinical hypercortisolemia","volume":"40","author":"Papierska","year":"2015","journal-title":"Abdom Imaging."},{"key":"2025012107400784000_63.12.1949.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2008.07.025"},{"key":"2025012107400784000_63.12.1949.9","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3181f4a16d"},{"key":"2025012107400784000_63.12.1949.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.064873"},{"key":"2025012107400784000_63.12.1949.11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4329\/wjr.v8.i6.635","article-title":"Endocrine radionuclide scintigraphy with fusion single photon emission computed tomography\/computed tomography","volume":"8","author":"Wong","year":"2016","journal-title":"World J Radiol."},{"key":"2025012107400784000_63.12.1949.12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.biopha.2016.12.090","article-title":"Contemporary imaging of incidentally discovered adrenal masses","volume":"87","author":"Wale","year":"2017","journal-title":"Biomed Pharmacother."},{"key":"2025012107400784000_63.12.1949.13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/MNM.0000000000000987","article-title":"Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan","volume":"40","author":"Wu","year":"2019","journal-title":"Nucl Med Commun."},{"key":"2025012107400784000_63.12.1949.14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jfma.2017.06.004","article-title":"Case detection and diagnosis of primary aldosteronism: the consensus of Taiwan Society of Aldosteronism","volume":"116","author":"Wu","year":"2017","journal-title":"J Formos Med Assoc."},{"key":"2025012107400784000_63.12.1949.15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cen.13442","article-title":"Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism","volume":"87","author":"Nanba","year":"2017","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2025012107400784000_63.12.1949.16","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1210\/jc.2018-02089","article-title":"Discordance between imaging and adrenal vein sampling in primary aldosteronism irrespective of interpretation criteria","volume":"104","author":"Sam","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2025012107400784000_63.12.1949.17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1537"},{"key":"2025012107400784000_63.12.1949.18","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jc.2015-3431","article-title":"A novel CYP11B2-specific imaging agent for detection of unilateral subtypes of primary aldosteronism","volume":"101","author":"Abe","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2025012107400784000_63.12.1949.19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nucmedbio.2018.11.002","article-title":"Development of [18F]FAMTO: a novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands","volume":"68\u201369","author":"Bongarzone","year":"2019","journal-title":"Nucl Med Biol."},{"key":"2025012107400784000_63.12.1949.20","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","article-title":"Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism","volume":"47","author":"Ding","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025012107400784000_63.12.1949.21","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1039\/C9TB01610D","article-title":"A self-assembled RNA-triple helix hydrogel drug delivery system targeting triple-negative breast cancer","volume":"8","author":"Ding","year":"2020","journal-title":"J Mater Chem B."},{"key":"2025012107400784000_63.12.1949.22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension."},{"key":"2025012107400784000_63.12.1949.23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0039-128X(82)90058-7","article-title":"Fluoro norcholesterol analogues. Synthesis of 6 beta-(2\u2032-fluoro) ethyl-19-norcholest-5(10)-en-3 beta-ol","volume":"39","author":"Kobayashi","year":"1982","journal-title":"Steroids."},{"key":"2025012107400784000_63.12.1949.24","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1248\/cpb.30.3082","article-title":"Synthesis of 7-fluoro-B-homo-19-norcholest-5(10)-En-3-beta-ol acetate","volume":"30","author":"Kobayashi","year":"1982","journal-title":"Chem Pharm Bull (Tokyo)."},{"key":"2025012107400784000_63.12.1949.25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0039-128X(77)90064-2","article-title":"Radio-bromine labeled nor-cholesterol analogs: synthesis and tissue distribution study in rats of Br-82 labeled 6beta-bromomethyl-19-norcholest-5(10)-En-3beta-ol","volume":"29","author":"Kojima","year":"1977","journal-title":"Steroids."},{"key":"2025012107400784000_63.12.1949.26","first-page":"1134","article-title":"The development of selenium-75 cholesterol analogues","volume":"207","author":"Riley","year":"1965","journal-title":"J Labelled Compd."},{"key":"2025012107400784000_63.12.1949.27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0037-1611845","article-title":"Synthesis of 6-(fluoromethyl)-19-norcholest-5(10)-en-3-ol, a fluorinated analogue of NP-59, using the mild fluorinating reagent, TBAF(Pinacol)(2)","volume":"3","author":"Winton","year":"2019","journal-title":"Synopen."},{"key":"2025012107400784000_63.12.1949.28","first-page":"976","article-title":"Improved synthesis and preclinical evaluation of [18F]FNP-59: a radiotracer for imaging cholesterol trafficking [abstract]","volume":"61","author":"Winton","year":"2020","journal-title":"J Nucl Med."},{"key":"2025012107400784000_63.12.1949.29","first-page":"1023","article-title":"OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J Nucl Med."},{"key":"2025012107400784000_63.12.1949.30","doi-asserted-by":"publisher","DOI":"10.1097\/00004032-200309000-00006"},{"key":"2025012107400784000_63.12.1949.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2005.02.037"},{"key":"2025012107400784000_63.12.1949.32","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfq286"},{"key":"2025012107400784000_63.12.1949.33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.apradiso.2014.01.033","article-title":"Ethanolic carbon-11 chemistry: the introduction of green radiochemistry","volume":"89","author":"Shao","year":"2014","journal-title":"Appl Radiat Isot."},{"key":"2025012107400784000_63.12.1949.34","doi-asserted-by":"crossref","first-page":"14805","DOI":"10.1039\/C5CC05919D","article-title":"Green approaches to late-stage fluorination: radiosyntheses of (18)F-labelled radiopharmaceuticals in ethanol and water","volume":"51","author":"Stewart","year":"2015","journal-title":"Chem Commun (Camb)."},{"key":"2025012107400784000_63.12.1949.35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108952"},{"key":"2025012107400784000_63.12.1949.36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110683"},{"key":"2025012107400784000_63.12.1949.37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110582"},{"key":"2025012107400784000_63.12.1949.38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mce.2006.12.001","article-title":"Adrenal cholesterol utilization","volume":"265\u2013266","author":"Kraemer","year":"2007","journal-title":"Mol Cell Endocrinol."},{"key":"2025012107400784000_63.12.1949.39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0005-2760(94)90096-5","article-title":"Evaluation in\u00a0vivo of the differential uptake and processing of high-density lipoprotein unesterified cholesterol and cholesteryl ester in the rat","volume":"1215","author":"Bravo","year":"1994","journal-title":"Biochim Biophys Acta."},{"key":"2025012107400784000_63.12.1949.40","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-020-00290-2"},{"key":"2025012107400784000_63.12.1949.41","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.226498"},{"key":"2025012107400784000_63.12.1949.42","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-52-4-612"},{"key":"2025012107400784000_63.12.1949.43","doi-asserted-by":"crossref","first-page":"644927","DOI":"10.3389\/fendo.2021.644927","article-title":"NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict KCNJ5 Mutation in Primary Aldosteronism Patients","volume":"12","author":"Lu","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"key":"2025012107400784000_63.12.1949.44","first-page":"1","article-title":"Radiation dose to patients from radiopharmaceuticals. ICRP publication 53","volume":"18","author":"International Commission on Radiological Protection (ICRP)","year":"1988","journal-title":"Ann ICRP."},{"key":"2025012107400784000_63.12.1949.45","unstructured":"Fludeoxyglucose F18 injection [package insert]. U.S. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021870s004lbl.pdf. Revised July 2010. Accessed September 13, 2022."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.122.263864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T16:12:57Z","timestamp":1737475977000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.122.263864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,1]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.2967\/jnumed.122.263864"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.122.263864","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]}}}